The centenarian blueprint: lessons in defying Parkinson's disease
- PMID: 39729254
- DOI: 10.1007/s00702-024-02875-y
The centenarian blueprint: lessons in defying Parkinson's disease
Erratum in
-
Correction: The centenarian blueprint: lessons in defying Parkinson's disease.J Neural Transm (Vienna). 2025 Mar 25. doi: 10.1007/s00702-025-02900-8. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 40131453 No abstract available.
Abstract
Recent advancements in neurology have shifted focus from mere diagnosis to comprehensive management of movement disorders, particularly Parkinson's Disease (PD), which is rapidly increasing in prevalence due to global ageing trends. While age is a key risk factor for PD, centenarians often exhibit a remarkably low prevalence of the disease, presenting an intriguing paradox. This viewpoint explores potential reasons for this low prevalence, drawing on studies from regions with high centenarian populations, known as Blue Zones. The authors highlight the importance of genetic, lifestyle, and environmental factors in promoting healthy ageing and examines how these may contribute to the resilience against PD found in centenarians. By understanding the protective mechanisms in centenarians, particularly the concept of hormesis and factors like diet, exercise, and social connections, we may inform prevention strategies for PD. The study proposes the "EAT, MOVE, SLEEP, PROTECT, and REPEAT" approach as a framework for lifestyle interventions to counteract PD risk factors. Ultimately, centenarians offer valuable insights into delaying neurodegeneration, providing a model for potential preventive trials for PD.
Keywords: Ageing; Centenarians; Parkinson’s disease; Parkinson’s disease prevention; Supercentenarians.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Conflict of interest statement
Declarations. Conflicts of interest: The authors declare no conflicts of interest.
Similar articles
-
Is Parkinson's Disease a Very Rare Pathology in Centenarians? A Clinical Study in a Cohort of Subjects.J Alzheimers Dis. 2020;73(1):73-76. doi: 10.3233/JAD-190717. J Alzheimers Dis. 2020. PMID: 31771058
-
New horizons in Parkinson's disease in older populations.Age Ageing. 2023 Oct 2;52(10):afad186. doi: 10.1093/ageing/afad186. Age Ageing. 2023. PMID: 37847793
-
Exploring Risk and Protective Factors in Parkinson's Disease.Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710. Cells. 2025. PMID: 40422213 Free PMC article. Review.
-
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?Neurobiol Dis. 2020 Feb;134:104671. doi: 10.1016/j.nbd.2019.104671. Epub 2019 Nov 6. Neurobiol Dis. 2020. PMID: 31706021 Review.
-
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project.Mech Ageing Dev. 2021 Mar;194:111426. doi: 10.1016/j.mad.2020.111426. Epub 2020 Dec 29. Mech Ageing Dev. 2021. PMID: 33385396
References
-
- Andersen-Ranberg K, Schroll M, Jeune B (2001) Healthy centenarians do not exist, but autonomous centenarians do: a population-based study of morbidity among Danish centenarians. J Am Geriatr Soc 49(7):900–908. https://doi.org/10.1046/j.1532-5415.2001.49180.x
-
- Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT (2012) Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol Biol Sci Med Sci 67(4):395–405. https://doi.org/10.1093/gerona/glr223 - DOI
-
- Arai Y, Sasaki T, Hirose N (2017) Demographic, phenotypic, and genetic characteristics of centenarians in Okinawa and Honshu, Japan: part 2 Honshu, Japan. Mech Ageing Dev 165(Pt B):80–85. https://doi.org/10.1016/j.mad.2017.02.005 - DOI - PubMed
-
- Bastos PAD, Barbosa R (2022) Motor reserve: how to build neuronal resilience against ageing and neurodegeneration? Rev Neurol (Paris) 178(8):845–854. https://doi.org/10.1016/j.neurol.2021.12.012 - DOI - PubMed
-
- Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G (2020) Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson’s disease: what do prospective studies suggest? Neurobiol Dis 134:104671. https://doi.org/10.1016/j.nbd.2019.104671 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical